Sensus Healthcare, Inc. SRTS
Set alert
At close · Oct 30
After hours · Oct 30, 4:00 PM ET
- YTD
- -30.65%
- 1 year
- -13.21%
- Open
- 2.75
- Prev close
- 2.78
- Mkt cap
- 45.44M
- Vol
- 27.77K
- Avg vol
- 30.54K
- EPS
- -0.94
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.75
- High
- 2.90
- Forward P/E
- 11.84
- Beta
- 1.04
- Short ratio
- 6.14
- Inst. own
- 24.27%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Feb 13, 2025
- 50-d avg
- 7.53
- 200-d avg
- 5.81
- 1y target
- 11.50
3M chart
Signals (15)
| Name | Date | Ago |
|---|---|---|
| MACD: Buy Signal | Oct 23, 2026 | 1 week ago |
| SMA: Bearish | Sep 18, 2026 | 1 month ago |
| SMA: Bullish | Sep 17, 2026 | 1 month ago |
| SMA: Bearish | Sep 15, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 4, 2026 | 1 month ago |
| RSI: Overbought | Aug 24, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 20, 2026 | 2 months ago |
| SMA: Bullish | Aug 18, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 17, 2026 | 2 months ago |
| SMA: Bearish | Aug 14, 2026 | 2 months ago |
| SMA: Bearish | Aug 14, 2026 | 2 months ago |
| SMA: Bullish | Aug 7, 2026 | 2 months ago |
| MACD: Buy Signal | Aug 7, 2026 | 2 months ago |
| SMA: Bullish | Aug 4, 2026 | 2 months ago |
Key statistics
- Market cap
- 112.60M
- Enterprise value
- 112.66M
- Trailing P/E
- 12.05
- Forward P/E
- 11.84
- PEG ratio
- 0.00
- Price / sales
- 3.10
- Price / book
- 4.39
- EPS (TTM)
- 0.57
- Beta
- 1.04
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 18.27%
- Revenue (TTM)
- 36.37M
- Revenue growth
- 155.70%
- Free cash flow
- -2.92M
- Total cash
- 14.52M
- Total debt
- 225.00K
- Return on equity
- 13.44%
- Shares outstanding
- 16.39M
- Short % of float
- 3.61%
- 50-day average
- 7.53
- 200-day average
- 5.81
Analyst view
Consensus: none
- Target (low)
- 10.00
- Target (mean)
- 11.50
- Target (high)
- 14.00
- Strong buy3
- Buy1
- Hold0
- Sell0
- Strong sell0
Next earnings
Feb 13, 2025
Expected Feb 13, 2025. Consensus EPS estimate 0.11333.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Feb 13, 2025 | Dec 1, 2024 | 0.10 | — | — | — |
| Nov 14, 2024 | Sep 1, 2024 | -0.02 | 0.07 | +0.09 | +450.00% |
| Aug 8, 2024 | Jun 1, 2024 | 0.03 | 0.10 | +0.07 | +233.33% |
| May 9, 2024 | Mar 1, 2024 | -0.04 | 0.14 | +0.18 | +450.00% |
| Feb 8, 2024 | Dec 1, 2023 | 0.12 | 0.26 | +0.14 | +116.67% |
| Nov 9, 2023 | Sep 1, 2023 | -0.01 | -0.09 | -0.08 | -800.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 18, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| Nov 15, 2024 | Maxim Group | main | Buy | Buy |
| Aug 12, 2024 | HC Wainwright & Co. | reit | Buy | Buy |
| May 13, 2024 | HC Wainwright & Co. | main | Buy | Buy |
| May 10, 2024 | Maxim Group | main | Buy | Buy |
| Nov 13, 2023 | HC Wainwright & Co. | reit | Buy | Buy |
About Sensus Healthcare, Inc.
Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy, a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating non-melanoma skin cancers, including basal cell and squamous cell skin cancers, as well as other skin conditions, such as keloids; and SRT-100 Vision, which provides the user with a superficial radiation therapy-tailored treatment planning application that integrates an embedded high frequency ultrasound imaging module, volumetric tumor analysis, beam margins planning, and dosimetry parameters. The company also provides SRT-100 Plus; Sentinel service program, which offers its customers protection for their systems; and Transdermal Infusion system, a biophysical alternative to infuse high weight molecule modalities into the dermis for medical and aesthetic purposes without the use of needles. In addition, it sells disposable lead shielding replacements; and disposable radiation safety items, such as aprons and eye shields, ultrasound probe film, and disposable applicator tips to treat various sized lesions and various areas of the body. Further, the company distributes laser devices, which includes applications for hair removal, vascular lesions, acne treatment, skin toning, and skin rejuvenation, as well as epidermal pigment removal for spots, freckles, and tattoos. It markets its products primarily to private dermatology practices, and radiation oncologists in both private and hospital settings. Sensus Healthcare, Inc. was incorporated in 2010 and is headquartered in Boca Raton, Florida.
- Sector
- Healthcare
- Industry
- Medical Devices
- Country
- United States
- Website
- sensushealthcare.com
News
- Lake Street Maintains Buy on Sensus Healthcare, Lowers Price Target to $4
- Applied Materials, Globant And 3 Stocks To Watch Heading Into Friday
- 12 Health Care Stocks Moving In Thursday's After-Market Session
- Full Transcript: Sensus Healthcare Q2 2026 Earnings Call
- Sensus Healthcare Q2 EPS $(0.53) Misses $(0.13) Estimate, Sales $2.290M Miss $4.601M Estimate
- 12 Health Care Stocks Moving In Friday's Intraday Session
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
- Why Akamai Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
- Sensus Healthcare Q1 EPS $(0.16) Misses $(0.13) Estimate, Sales $3.394M Miss $5.323M Estimate
- 12 Health Care Stocks Moving In Monday's After-Market Session
Your note
Sign in to keep a note on SRTS — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| CORNISH MEGAN | Director | Stock Award(Grant) | Dec 16, 2024 | 32,000 |
| HEINRICH JOHN P. PH.D. | Director | Sale | May 19, 2024 | 59,940 |
| MCCALL WILLIAM H | Director | Stock Award(Grant) | Dec 16, 2024 | 30,000 |
| O'REAR SAMUEL | Director | Purchase | May 8, 2023 | 143,570 |
| PETRELLI ANTHONY BENEDICT | Director | Stock Award(Grant) | Dec 16, 2024 | 66,466 |
| SARDANO JOSEPH C | Chief Executive Officer | Purchase | Sep 13, 2023 | 1,175,290 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Group Inc | 4.75% | 779,052 | 5.35M | Sep 29, 2024 |
| Renaissance Technologies, LLC | 2.50% | 409,334 | 2.81M | Sep 29, 2024 |
| Acadian Asset Management. LLC | 1.85% | 303,915 | 2.09M | Sep 29, 2024 |
| Dimensional Fund Advisors LP | 1.77% | 289,615 | 1.99M | Sep 29, 2024 |
| Morgan Stanley | 1.13% | 185,268 | 1.27M | Sep 29, 2024 |
| Two Sigma Investments, LP | 0.94% | 154,044 | 1.06M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 3.39% | 555,562 | 3.82M | Sep 29, 2024 |
| Vanguard Extended Market Index Fund | 1.27% | 207,423 | 1.42M | Sep 29, 2024 |
| Perritt Microcap Opportunities Fund | 0.58% | 95,000 | 652.65K | Sep 29, 2024 |
| Fidelity Extended Market Index Fund | 0.46% | 76,080 | 522.67K | Oct 30, 2024 |
| Unified Series Trust-Auer Growth Fd | 0.31% | 50,000 | 343.50K | Oct 30, 2024 |
| iShares Micro Cap ETF | 0.21% | 34,229 | 235.15K | Oct 30, 2024 |